Gene | Substitutions/indel | Amplification | Loss | Truncation | Fusion/rearrangement | Total no. |
---|---|---|---|---|---|---|
TP53 | 32 | 0 | 1 | 12 | 0 | 45 |
KRAS | 43 | 0 | 0 | 0 | 0 | 43 |
CDKN2A | 3 | 0 | 16 | 9 | 0 | 28 |
CDKN2B | 0 | 0 | 14 | 1 | 0 | 15 |
SMAD4 | 3 | 0 | 3 | 9 | 0 | 15 |
ARID1A | 2 | 0 | 0 | 11 | 0 | 13 |
ERBB2 | 6 | 3 | 0 | 0 | 0 | 9 |
PBRM1 | 1 | 0 | 0 | 7 | 1 | 9 |
PTEN | 1 | 0 | 2 | 4 | 0 | 7 |
APC | 0 | 0 | 0 | 6 | 0 | 6 |
ATM | 1 | 0 | 0 | 5 | 0 | 6 |
MYC | 0 | 6 | 0 | 0 | 0 | 6 |
NF1 | 0 | 0 | 0 | 6 | 0 | 6 |
CCND1 | 0 | 5 | 0 | 0 | 0 | 5 |
FBXW7 | 3 | 0 | 0 | 2 | 0 | 5 |
FGF3/4/19 | 0 | 5 | 0 | 0 | 0 | 5 |
GNAS | 5 | 0 | 0 | 0 | 0 | 5 |
MDM2 | 0 | 5 | 0 | 0 | 0 | 5 |
NRAS | 4 | 1 | 0 | 0 | 0 | 5 |
Shaded rows are classified as clinically relevant genomic alterations.